Seed Round - SyntheX
Investment Firm
Overview
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Announced Date
Mar 01, 2017
Closed on Date
Apr 20, 2017
Funding Type
Seed
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
| Investor Name |
|---|
 Morgan Noble |
 Oriza Ventures |
 8VC |
Round Details and Background
SyntheX raised $6150000 on 2017-03-01 in Seed Round
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 27, 2022 |  Convertible Note - SyntheX | 2 | - | undefined |
| Dec 29, 2023 | Venture Round - SyntheX | - | 5.2M | |
| Mar 01, 2017 | Seed Round - SyntheX | 4 | - | 6.2M |
| Mar 10, 2016 | Convertible Note - SyntheX | 2 | - | 250.0K |
Recent Activity
There is no recent news or activity for this profile.